ArticleHemaSphere2024
Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies.
Roger E G SchutgensPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it